Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    EV demand grows across Europe in Q1

    April 20, 2026

    Manchester City cut Arsenal lead with Haaland strike

    April 20, 2026

    Belvilla and Flying Blue, Loyalty program of Air France-KLM partner to Expand Miles Redemption into Vacation Rentals

    April 20, 2026
    Trending
    • EV demand grows across Europe in Q1
    • Manchester City cut Arsenal lead with Haaland strike
    • Belvilla and Flying Blue, Loyalty program of Air France-KLM partner to Expand Miles Redemption into Vacation Rentals
    • EU trade surplus with rest of world drops in February
    • International law under pressure UN chief tells court
    • WEF links AI adoption to next phase of global growth
    • Satellite safety algorithm speeds orbit tracking in Russia
    • EU leaders set Cyprus summit agenda on security and budget
    • Home
    • Contact Us
    Buckingham DailyBuckingham Daily
    Tuesday, April 21
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Buckingham DailyBuckingham Daily
    Home » Brewing hope – how used coffee grounds may combat Alzheimer’s and Parkinson’s
    Health

    Brewing hope – how used coffee grounds may combat Alzheimer’s and Parkinson’s

    November 22, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    In the relentless battle against neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Huntington’s, a groundbreaking discovery emerges from The University of Texas at El Paso. Researchers, exploring the unlikeliest of sources—spent coffee grounds—have unearthed a potential weapon against these debilitating conditions that afflict millions and strain healthcare budgets with hundreds of billions in annual costs.

    Brewing hope - how used coffee grounds may combat Alzheimer's and Parkinson's

    Leading the charge is Jyotish Kumar, a doctoral student in the Department of Chemistry and Biochemistry, along with Mahesh Narayan, Ph.D., a distinguished professor and Royal Society of Chemistry Fellow. Their team has identified caffeic-acid based Carbon Quantum Dots (CACQDs), derivable from used coffee grounds, as a promising agent in shielding brain cells from damage typically associated with neurodegenerative diseases, particularly those exacerbated by factors like obesity, aging, and exposure to environmental toxins.

    Their findings, detailed in the journal Environmental Research, mark a significant leap forward. “CACQDs could revolutionize neurodegenerative disease treatment,” Kumar states. Unlike existing therapies that merely manage symptoms, CACQDs aim at the root causes – the molecular triggers of these ailments. Neurodegenerative diseases, characterized by neuron loss, impair basic and complex functions—from movement and speech to cognitive abilities.

    Lifestyle and environmental factors in early stages of these diseases often lead to increased free radicals and amyloid protein fragment aggregation in the brain, contributing to the progression of these conditions. Kumar’s team discovered that CACQDs offer neuroprotection in various models of Parkinson’s disease, particularly those induced by the pesticide paraquat. The CACQDs demonstrated an ability to neutralize free radicals and prevent amyloid protein aggregation, all without notable side effects.

    This breakthrough suggests that early intervention with CACQD-based treatments could thwart the full onset of diseases like Alzheimer’s and Parkinson’s. Caffeic acid, a polyphenol known for its antioxidant properties, is uniquely capable of crossing the blood-brain barrier, thus directly impacting brain cells. The team’s “green chemistry” approach to extracting CACQDs from coffee waste—cooking grounds at 200° for four hours—is both eco-friendly and cost-effective, making this a sustainable solution.

    The project, encompassing contributions from numerous UTEP graduate and undergraduate students, including Sofia Delgado, now a Ph.D. student at Yale University, signifies a collective effort in scientific advancement. While Narayan and Kumar acknowledge the journey ahead is long, the potential of developing a simple, pill-based preventative treatment for the majority of non-genetically caused neurodegenerative disorders remains a beacon of hope.

    Related Posts

    Russian study finds spruce compounds slow blood clotting

    April 8, 2026

    WHO urges global support for science on World Health Day

    April 7, 2026

    EU commits 225 million euros for next-gen flu vaccines

    February 24, 2026

    WHO clears another nOPV2 polio vaccine for global UNICEF use

    February 14, 2026

    WHO and IARC say 37% of cancer cases are preventable

    February 4, 2026

    Russia researchers develop berberine cheese to support immunity

    January 28, 2026

    Latest News

    EV demand grows across Europe in Q1

    April 20, 2026

    Manchester City cut Arsenal lead with Haaland strike

    April 20, 2026

    EU trade surplus with rest of world drops in February

    April 18, 2026

    International law under pressure UN chief tells court

    April 18, 2026

    WEF links AI adoption to next phase of global growth

    April 17, 2026

    Satellite safety algorithm speeds orbit tracking in Russia

    April 17, 2026

    EU leaders set Cyprus summit agenda on security and budget

    April 16, 2026

    EU fossil fuel bill jumps as Middle East conflict bites

    April 14, 2026
    © 2024 Buckingham Daily | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.